CFRA has a "buy" rating and $1,045 price target for LLY stock, which closed at $789.09 on April 3. Johnson & Johnson is a global leader in the pharmaceutical, medical device and consumer health ...

Huckman, Robert S., Rosabeth Moss Kanter, Antonio Moreno, Bradley Staats, and Sarah Mehta. "Best Buy Health: Enabling Care at Home." Harvard Business School Case 624-009, February 2024. (Revised ...